- A joint initiative of BADAS and Novo Nordisk Pharma (Pvt)
- Objectives: 1) To evaluate the countrywide prevalence of GDM and its associated risk factors in Bangladesh. 2) To evaluate the knowledge about GDM among pregnant women in Bangladesh.
- Study design: Cross-sectional study
- Study duration: 12 months (November 2017 to November 2018)
- Study centers: 100 institutions of BADAS and its AAs
- Target population: Pregnant women who are living in the localities close to the selected centers
- Total study samples: 7000
- Funding: Novo Nordisk Pharma (Pvt)
- Status: Complete
- Key points:
- According to the preliminary findings, the rate of GDM is 26.4%, and the rate of good knowledge about GDM is only 26.3%.
Screening for Gestational Diabetes Mellitus and its Prevalence in Bangladesh
